Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies.
Carrillo De Albornoz S, Higgins AM, Petrie D, Irving A, Fanning L, Weinkove R, Crispin P, Dendle C, Gilbertson M, Johnston AM, Keegan A, Pepperell D, Pullon HW, Reynolds J, van Tonder T, Trotman J, Waters N, Wellard C, Weston H, Morrissey O, Wood EM, McQuilten Z. Carrillo De Albornoz S, et al. Among authors: fanning l. Blood Adv. 2024 Mar 14:bloodadvances.2023012047. doi: 10.1182/bloodadvances.2023012047. Online ahead of print. Blood Adv. 2024. PMID: 38484199
Robust cross-cohort gut microbiome associations with COVID-19 severity.
Li J, Ghosh TS, McCann R, Mallon P, Hill C, Draper L, Schult D, Fanning LJ, Shannon R, Sadlier C, Horgan M, O'Mahony L, O'Toole PW. Li J, et al. Among authors: fanning lj. Gut Microbes. 2023 Jan-Dec;15(1):2242615. doi: 10.1080/19490976.2023.2242615. Gut Microbes. 2023. PMID: 37550964 Free PMC article.
Impact of Airway Virus in Severe Asthmatic Patients: A Pilot Study.
Walsh LJ, Sullivan A, Ward C, Fanning LJ, O'Byrne PM, MacSharry JA, Murphy DM. Walsh LJ, et al. Among authors: fanning lj. Allergy Asthma Immunol Res. 2023 May;15(3):406-411. doi: 10.4168/aair.2023.15.3.406. Epub 2023 Jan 9. Allergy Asthma Immunol Res. 2023. PMID: 37075793 Free PMC article.
Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study.
Benatar M, Wuu J, Andersen PM, Bucelli RC, Andrews JA, Otto M, Farahany NA, Harrington EA, Chen W, Mitchell AA, Ferguson T, Chew S, Gedney L, Oakley S, Heo J, Chary S, Fanning L, Graham D, Sun P, Liu Y, Wong J, Fradette S. Benatar M, et al. Among authors: fanning l. Neurotherapeutics. 2022 Sep;19(5):1686. doi: 10.1007/s13311-022-01286-9. Neurotherapeutics. 2022. PMID: 36175782 Free PMC article. No abstract available.
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S; VALOR and OLE Working Group. Miller TM, et al. Among authors: fanning l. N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705. N Engl J Med. 2022. PMID: 36129998 Free article. Clinical Trial.
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study.
Benatar M, Wuu J, Andersen PM, Bucelli RC, Andrews JA, Otto M, Farahany NA, Harrington EA, Chen W, Mitchell AA, Ferguson T, Chew S, Gedney L, Oakley S, Heo J, Chary S, Fanning L, Graham D, Sun P, Liu Y, Wong J, Fradette S. Benatar M, et al. Among authors: fanning l. Neurotherapeutics. 2022 Jul;19(4):1248-1258. doi: 10.1007/s13311-022-01237-4. Epub 2022 May 18. Neurotherapeutics. 2022. PMID: 35585374 Free PMC article. Clinical Trial.
122 results